In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 56 for your search:
Drug:  flutamide
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: RTOG-9408, CDR0000063821, NCT00002597

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: RTOG-9413, CDR0000063822, NCT00769548

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: SWOG-S9615, SWOG-9615, S9615

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: E-8892, CLB-E8892, SWOG-E8892, NCT00002881, E8892

6.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: RTOG-9608, RTOG-96-08

7.

Phase: Phase III
Type: Health services research, Treatment
Status: Completed
Age: Any age
Sponsor: Other
Protocol IDs: EORTC-22961, EORTC-GU-22961, NCT00003026

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: ID97-077, P30CA016672, MDA-ID-97077, E-97077, NCI-T97-0069, CDR0000066733, NCI-2009-00818, T97-0069, NCT00003645

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ICORG-97-01, EU-98060, NCT00003734

10.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: RTOG-9902, CDR0000067250, RTOG-DEV-1020, NCT00004054

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-9910, CDR0000067635, NCT00005044

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: RTOG-P-0011, CDR0000068868, RTOG-DEV-1037, CAN-NCIC-PR9, PR9, NCT00023829

13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG-P-0014, CDR0000069186, RTOG-DEV-1028, ECOG-RTOG-P-0014, CALGB-RTOG-P-0014, SWOG-RTOG-P-0014, NCT00030654

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: EST-5883

15.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8494, MAOP-4384, NCCTG-INT-0036, NCOG-4P842J, NPCTG-2200, INT-0036

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: RUSH-C83-06306, NCI-V85-0003

17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: EORTC-30853

18.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: RTOG-8610, RTOG-86-10

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: SWOG-8894, EST-2889, INT-0105

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 20 to 80
Sponsor:
Protocol IDs: MDA-DM-88027, NCI-V88-0440

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-30892

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-30903

23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 45 to 70
Sponsor: NCI
Protocol IDs: MSKCC-92010, NCI-H92-0057

24.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 50 and over
Sponsor: NCI
Protocol IDs: RTOG-9202, RTOG-92-02, NCT00767286

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: MSKCC-92050, NCI-V92-0124
1    
New Search